Assembly Biosciences (V7B) Q2 2026 Earnings Report
DE:V7B Q2 2026 EPS Results
- Actual EPS
- -EUR 0.18
- Consensus EPS
- -EUR 0.65
- Beat/Miss
- Beat by +EUR 0.47
- One Year Ago EPS
- -EUR 1.19
DE:V7B Q2 2026 Revenue Results
- Actual Revenue
- EUR 11.98M
- Expected Revenue
- EUR 7.70M
- Beat/Miss
- Beat by +EUR 4.28M
- YoY Revenue Growth
- +38.94%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
DE:V7B Upcoming Earnings
Assembly Biosciences's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:V7B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.59- | -0.64 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.65-0.18 | -1.19 | 84.96% (+1.01) | |
| May 07, 2026 | 2026 (Q1) | -0.58-0.48 | -1.05 | 53.85% (+0.56) | |
| Mar 19, 2026 | 2025 (Q4) | -0.771.25 | -1.38 | 190.45% (+2.63) | |
| Nov 10, 2025 | 2025 (Q3) | -0.74-0.64 | -1.35 | 52.32% (+0.71) | |
| Aug 06, 2025 | 2025 (Q2) | -1.55-1.19 | -1.77 | 32.83% (+0.58) | |
| May 08, 2025 | 2025 (Q1) | -1.43-1.05 | -1.49 | 29.52% (+0.44) | |
| Mar 20, 2025 | 2024 (Q4) | -1.61-1.38 | -1.67 | 17.20% (+0.29) | |
| Nov 07, 2024 | 2024 (Q3) | -2.06-1.35 | -2.9 | 53.40% (+1.55) | |
| Aug 08, 2024 | 2024 (Q2) | -2.00-1.77 | -3.44 | 48.44% (+1.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed